🔴 Exclusive webinar: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

Pharma Reaserch Products Co Ltd (214450)

KOSDAQ
Currency in KRW
221,500
+2,500(+1.14%)
Closed
214450 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected today
Fair Value
Day's Range
215,500225,000
52 wk Range
86,800241,500
Key Statistics
Edit
Bid/Ask
221,500.00 / 222,000.00
Prev. Close
219,000
Open
216,000
Day's Range
215,500-225,000
52 wk Range
86,800-241,500
Volume
107,704
Average Volume (3m)
206,195
1-Year Change
82.42%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
214450 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
253,857.00
Upside
+14.61%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years
Show more

Pharma Reaserch Products Co Ltd Company Profile

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults through the physical restoration; Rejuran HB plus which is used for temporary improvement of adult's crow's feet wrinkles; Rejuvenex injection, a tissue regeneration activator that regenerates connective tissues, including ligament, tendon, skin, etc.; and Rejuvenex cream, which treats the wound through rapid tissue regeneration. It also provides REJURAN, a medical device for face (especially eye, perioral area), neck, Décolleté, hands, etc; CLEVIEL prime plus and contour plus with lidocaine medical devices; D+CELL 350 TRA I; and REJURAN moisturizer for daily skin protection, as well as REJUVENEX SCULPT V; REJURAN concentrate for sensitive and aged skin; REJURAN healing eye gel and mask; REJURAN sunscreen that protects skin from UV rays; and REJURAN recover soothing mask. In addition, the company offers D+CELL 350 TRA concentrated rejuvenation cream, intensive repair serum, activating facial toner, high potency eye lift, moisture balancer, mask, hair, cream, and hydro products; REJURAN tone-up booster; REJURAN FORTE; and CONJURAN medical devices. Further, it offers functional foods; and engages in the development of software and consulting businesses. The company was formerly known as Pharma Research Products Co., Ltd. and changed its name to PharmaResearch Co., Ltd. in April 2021. PharmaResearch Co., Ltd. was founded in 1993 and is headquartered in Gangneung-si, South Korea.

Employees
354

Compare 214450 to Peers and Sector

Metrics to compare
214450
Peers
Sector
Relationship
P/E Ratio
25.1x−10.4x−0.6x
PEG Ratio
0.520.050.00
Price/Book
4.7x2.2x2.6x
Price / LTM Sales
7.7x5.3x3.2x
Upside (Analyst Target)
9.1%36.7%43.4%
Fair Value Upside
Unlock5.6%6.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8886.7
Dividend Yield
0.43%
Industry Median 0.27%
Annualised payout
950
Paid annually
5-Years Growth
+25.93%
Growth Streak

People Also Watch

445,500
196170
+1.95%
281,000
145020
-5.07%
140,000
141080
+7.20%
38,200
257720
-7.39%
339,000
128940
+4.95%

FAQ

What Is the Pharma Reaserch Products (214450) Stock Price Today?

The Pharma Reaserch Products stock price today is 221,500.00

What Stock Exchange Does Pharma Reaserch Products Trade On?

Pharma Reaserch Products is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Pharma Reaserch Products?

The stock symbol for Pharma Reaserch Products is "214450."

Does Pharma Reaserch Products Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 0.43%.

What Is the Pharma Reaserch Products Market Cap?

As of today, Pharma Reaserch Products market cap is 2.28T.

What is Pharma Reaserch Products Earnings Per Share?

The Pharma Reaserch Products EPS is 8,886.70.

What Is the Next Pharma Reaserch Products Earnings Date?

Pharma Reaserch Products will release its next earnings report on 10 Nov 2024.

From a Technical Analysis Perspective, Is 214450 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.